Semaglutide providers: compare the actual product and plan

How to use this comparison

The word semaglutide does not establish the finished product, route, approval status, or pharmacy assignment.

CoreAge Rx has a commercial first position in this guide. We may be compensated through its links. The sequence is not an independently calculated medical ranking, and inclusion does not mean every service supplies every feature discussed here.

Use the documents for the actual treatment, location, and payment agreement. A service may be useful to compare even when its approach differs: a consultation-only pathway, an inclusive package, and a care membership should not be assumed to buy the same thing.

• Name the exact care service.
• Request the complete payment schedule.
• Check the product, pharmacy, and exit terms.

01. CoreAge Rx — commercial first position

This is the featured commercial partner. The placement should not be interpreted as proof of superior outcomes, lower total cost, or the best clinical choice for a particular person.

CoreAge Rx describes assessment online followed by dispensing when a clinician issues a prescription. It is Panda Bear’s commercial partner; that arrangement determines its featured position, not an assessment of treatment quality.

Its offer advertises semaglutide from $99 and tirzepatide from $149. The billing help uses $447 paid for three months to illustrate a $149 monthly equivalent. No additional membership fee is advertised, but the selected product and supply period still control the invoice.

Will my receipt show one payment or recurring charges, and which pharmacy will be on the label?

Open our CoreAge Rx review for the terms, evidence limits, and published contact routes.

02. Mochi Health

Mochi’s membership provides the care arrangement; its medication bill is additional. An August 2026 explanation describes medication prices that vary by tier, so older flat-price descriptions need checking.

The standard membership is $79 monthly, with a $39 introductory month advertised. Published medication ranges are $60–$99 for semaglutide and $90–$199 for tirzepatide. These ranges are not instructions to choose a dose according to price.

What is the recurring total at the tier my clinician prescribes, and on which dates are the two charges taken?

Open our Mochi Health review for the terms, evidence limits, and published contact routes.

03. Henry Meds

Henry Meds offers several weight-management arrangements with remote assessment. Its FAQ describes care, supplies, and prescribed medicine within packages, including different formulations and treatment durations.

GLP-1 programs are advertised from $179 monthly. The selected route and agreement matter: an oral compound, an injection, and a longer purchase should each be quoted explicitly rather than grouped under that starting number.

What would remain owed if treatment stopped halfway through the agreement, and which exception rules could apply?

Open our Henry Meds review for the terms, evidence limits, and published contact routes.

04. OrderlyMeds

OrderlyMeds describes screening and provider review before a pharmacy prepares a prescription. Its pages distinguish starter treatment, ongoing treatment, and branded options.

Eligible starters are offered two months of compounded semaglutide for $149 or tirzepatide for $299. Those package averages are $74.50 and $149.50 respectively; they do not establish the maintenance price or eligibility for an existing patient.

What will the first refill after this starter package cost, and am I eligible for the starter offer?

Open our OrderlyMeds review for the terms, evidence limits, and published contact routes.

05. Eden

Eden presents personalized weight care and directs members to its patient system. To understand the purchase, identify the care membership separately from the pharmacy transaction, even if enrollment presents them together.

A $99 compounded-semaglutide starting offer carries a membership qualification. The accessible homepage does not establish a universal combined total. Ask for both components, the length of the offer, and the later refill amount.

What does the membership add to the drug price, and what evidence concerns the exact formulation being proposed?

Open our Eden review for the terms, evidence limits, and published contact routes.

06. Ivím Health

Ivím promotes continuing support alongside medication plans. Program-outcome material on its website is observational evidence about a program, not a randomized trial of every compounded preparation it may arrange.

The captured offer shows six-month drug equivalents of $75 for semaglutide and $133 for tirzepatide. Membership is separately advertised at $75 monthly with the first month free. Ask how both commitments align before using either drug figure as the total.

How much of the medication term requires paid membership, and how would each charge change if treatment ended?

Open our Ivím Health review for the terms, evidence limits, and published contact routes.

07. Ro

Ro’s Body pathway describes branded medication access and help with insurance. Membership, prescribing review, and the pharmacy benefit remain distinct parts of the arrangement.

The membership offer shows $39 initially, then $149 monthly. An annual payment can produce a $74 monthly equivalent. None of those membership amounts includes the medicine itself; insurance or the cash-pay pharmacy price must be added.

If insurance refuses the medicine, what will I already have paid for care and what options remain?

Open our Ro review for the terms, evidence limits, and published contact routes.

Make the comparison specific to you

After reading the options, select the questions you still need answered. Ask each provider for the same time period, named prescription, and clinical access. Record unclear items as unresolved instead of choosing the lowest advertised number.

If the medicine, route, or treatment goal differs, discuss that difference with the clinician before treating it as an ordinary shopping substitution. The cost worksheet can help compare payments while keeping the medical decision separate.